{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:54:20Z","timestamp":1795136060569,"version":"4.10.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Hospitals Authority","award":["NO.XTCX201820"],"award-info":[{"award-number":["NO.XTCX201820"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sepsis is a primary global health threat and costs a lot, requiring effective and affordable treatments. We performed this meta-analysis to explore the treatment of hydrocortisone, ascorbic acid, and thiamine (HAT) in sepsis and septic shock.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched Ovid MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials from inception to August 14, 2021. We included randomized controlled trials (RCTs) that evaluated the HAT treatments in sepsis and septic shock. The primary outcome was the change in SOFA score over the 72\u00a0h. The second outcomes were the hospital, and 28-\/30-day mortality, the duration of vasopressors, PCT clearance, hospital length of stay (LOS), and ICU LOS. We performed a subgroup analysis and a trial sequential analysis (TSA). The Der Simonian\u2013Laird random-effects models were used to report the pooled risk ratios (RR) or mean difference (MD) with confidence intervals (CI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nine RCTs, enrolling 1427 patients of sepsis and septic shock treated with HAT (717) or only standard care (710), were included. There was a significant difference between the two groups in the change in SOFA score over the first 72\u00a0h (MD 0.65, 95% CI 0.30 to 1.00), the duration of vasopressors (MD \u2212\u200918.16, 95% CI \u2212\u200925.65 to \u2212\u200910.68) and the PCT clearance (MD 14.54, 95% CI 0.64 to 28.43). In addition, there was no significant difference in the hospital mortality (RR 1.07, 95% CI 0.85 to 1.34), the 28-\/30-day mortality (RR 0.96, 95% CI 0.80 to 1.15), the hospital LOS (MD 0.78, 95% CI \u2212\u20090.30 to 1.86), and ICU LOS (MD 0.12, 95% CI \u2212\u20090.53 to 0.78).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The HAT combination improves the SOFA score in the first 72\u00a0h and reduces the duration of vasopressors in patients with sepsis. Given the minor mean difference of the change in SOFA score, the mortality benefit has not been observed.<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:italic>Trial registration<\/jats:italic><\/jats:title><jats:p>PROSPERO, CRD42020203166.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40560-021-00589-x","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T11:14:26Z","timestamp":1639826066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hydrocortisone, ascorbic acid, and thiamine (HAT) for sepsis and septic shock: a meta-analysis with sequential trial analysis"],"prefix":"10.1186","volume":"9","author":[{"given":"Weilan","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,18]]},"reference":[{"issue":"8","key":"589_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"1","key":"589_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13054-018-2157-z","volume":"22","author":"KE Rudd","year":"2018","unstructured":"Rudd KE, Kissoon N, Limmathurotsakul D, Bory S, Mutahunga B, Seymour CW, et al. The global burden of sepsis: barriers and potential solutions. Crit Care. 2018;22(1):232.","journal-title":"Crit Care"},{"issue":"6","key":"589_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","volume":"151","author":"PE Marik","year":"2017","unstructured":"Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before\u2013after study. Chest. 2017;151(6):1229\u201338.","journal-title":"Chest"},{"issue":"4","key":"589_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1164\/rccm.200205-446OC","volume":"167","author":"D Keh","year":"2003","unstructured":"Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, et al. Immunologic and hemodynamic effects of \u201clow-dose\u201d hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med. 2003;167(4):512\u201320.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"589_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/ajcn\/63.5.760","volume":"63","author":"CJ Schorah","year":"1996","unstructured":"Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, Sanderson MJ, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996;63(5):760\u20135.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"589_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.21037\/jtd.2016.04.32","volume":"8","author":"J Mallat","year":"2016","unstructured":"Mallat J, Lemyze M, Thevenin D. Do not forget to give thiamine to your septic shock patient! J Thorac Dis. 2016;8(6):1062\u20136.","journal-title":"J Thorac Dis"},{"issue":"1","key":"589_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13054-018-2217-4","volume":"22","author":"A Moskowitz","year":"2018","unstructured":"Moskowitz A, Andersen LW, Huang DT, Berg KM, Grossestreuer AV, Marik PE, et al. Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation. Crit Care. 2018;22(1):283.","journal-title":"Crit Care"},{"issue":"5","key":"589_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.chest.2017.07.014","volume":"152","author":"N Barabutis","year":"2017","unstructured":"Barabutis N, Khangoora V, Marik PE, Catravas JD. Hydrocortisone and ascorbic acid synergistically prevent and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Chest. 2017;152(5):954\u201362.","journal-title":"Chest"},{"issue":"1","key":"589_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-2217-4","volume":"22","author":"A Moskowitz","year":"2018","unstructured":"Moskowitz A, Andersen LW, Huang DT, Berg KM, Grossestreuer AV, Marik PE, et al. Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation. Crit Care. 2018;22(1):1\u20137.","journal-title":"Crit Care"},{"issue":"4","key":"589_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4239\/wjd.v11.i4.90","volume":"11","author":"PE Marik","year":"2020","unstructured":"Marik PE, Varon J, Surani SR. Hydrocortisone, ascorbic acid and thiamine for sepsis: is the jury out? World J Diabetes. 2020;11(4):90\u20134.","journal-title":"World J Diabetes"},{"issue":"4","key":"589_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/23744235.2020.1718200","volume":"52","author":"SJ Wani","year":"2020","unstructured":"Wani SJ, Mufti SA, Jan RA, Shah SU, Qadri SM, Khan UH, et al. Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: results from an open label randomised controlled clinical trial and a review of the literature. Infect Dis. 2020;52(4):271\u20138.","journal-title":"Infect Dis"},{"issue":"1","key":"589_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.chest.2020.02.065","volume":"158","author":"P Chang","year":"2020","unstructured":"Chang P, Liao Y, Guan J, Guo Y, Zhao M, Hu J, et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock: a randomized controlled trial. Chest. 2020;158(1):174\u201382.","journal-title":"Chest"},{"issue":"7","key":"589_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jama.2020.11946","volume":"324","author":"A Moskowitz","year":"2020","unstructured":"Moskowitz A, Huang DT, Hou PC, Gong J, Doshi PB, Grossestreuer AV, et al. Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS Randomized Clinical Trial. JAMA. 2020;324(7):642\u201350.","journal-title":"JAMA"},{"issue":"11","key":"589_CR14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1164\/rccm.202005-1829OC","volume":"202","author":"EA Vail","year":"2020","unstructured":"Vail EA, Wunsch H, Pinto R, Bosch NA, Walkey AJ, Lindenauer PK, et al. Use of hydrocortisone, ascorbic acid, and thiamine in adults with septic shock. Am J Respir Crit Care Med. 2020;202(11):1531\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"589_CR15","unstructured":"Group P. Preferred reporting items for systematic reviews and meta\u2011analyses (PRISMA) http:\/\/prisma-statement.org\/."},{"key":"589_CR16","doi-asserted-by":"crossref","unstructured":"Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane. 2019.","DOI":"10.1002\/9781119536604"},{"issue":"1","key":"589_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","volume":"17","author":"J Wetterslev","year":"2017","unstructured":"Wetterslev J, Jakobsen JC, Gluud C. Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17(1):39.","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"589_CR18","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4103\/ija.IJA_361_18","volume":"62","author":"M Balakrishnan","year":"2018","unstructured":"Balakrishnan M, Gandhi H, Shah K, Pandya H, Patel R, Keshwani S, et al. Hydrocortisone, vitamin C and thiamine for the treatment of sepsis and septic shock following cardiac surgery. Indian J Anaesth. 2018;62(12):934\u20139.","journal-title":"Indian J Anaesth"},{"issue":"1","key":"589_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.chest.2020.02.049","volume":"158","author":"J Iglesias","year":"2020","unstructured":"Iglesias J, Vassallo AV, Patel VV, Sullivan JB, Cavanaugh J, Elbaga Y. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: The ORANGES Trial. Chest. 2020;158(1):164\u201373.","journal-title":"Chest"},{"issue":"8","key":"589_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.5005\/jp-journals-10071-23517","volume":"24","author":"ZU Mohamed","year":"2020","unstructured":"Mohamed ZU, Prasannan P, Moni M, Edathadathil F, Prasanna P, Menon A, et al. Vitamin c therapy or routine care in septic shock (ViCTOR) trial: effect of intravenous vitamin C, thiamine, and hydrocortisone administration on inpatient mortality among patients with septic shock. Indian J Crit Care Med. 2020;24(8):653\u201361.","journal-title":"Indian J Crit Care Med"},{"issue":"8","key":"589_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/jama.2020.24505","volume":"325","author":"JE Sevransky","year":"2021","unstructured":"Sevransky JE, Rothman RE, Hager DN, Bernard GR, Brown SM, Buchman TG, et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis- and VICTAS randomized clinical trial. JAMA. 2021;325(8):742\u201350.","journal-title":"JAMA"},{"issue":"5","key":"589_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2019.22176","volume":"323","author":"T Fujii","year":"2020","unstructured":"Fujii T, Luethi N, Young PJ, Frei DR, Eastwood GM, French CJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS Randomized Clinical Trial. JAMA. 2020;323(5):423\u201331.","journal-title":"JAMA"},{"issue":"9","key":"589_CR23","doi-asserted-by":"publisher","first-page":"e14376","DOI":"10.1111\/ijcp.14376","volume":"75","author":"AA Hussein","year":"2021","unstructured":"Hussein AA, Sabry NA, Abdalla MS, Farid SF. A prospective, randomised clinical study comparing triple therapy regimen to hydrocortisone monotherapy in reducing mortality in septic shock patients. Int J Clin Pract. 2021;75(9):e14376.","journal-title":"Int J Clin Pract"},{"issue":"8","key":"589_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.5005\/jp-journals-10071-23515","volume":"24","author":"PR Reddy","year":"2020","unstructured":"Reddy PR, Samavedam S, Aluru N, Yelle S, Rajyalakshmi B. Metabolic resuscitation using hydrocortisone ascorbic acid thiamine: do individual components influence reversal of shock independently? Indian J Crit Care Med. 2020;24(8):649\u201352.","journal-title":"Indian J Crit Care Med"},{"issue":"1","key":"589_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","volume":"23","author":"S Lambden","year":"2019","unstructured":"Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374.","journal-title":"Crit Care"},{"issue":"8","key":"589_CR26","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):762\u201374.","journal-title":"JAMA"},{"issue":"7","key":"589_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1164\/rccm.201908-1543LE","volume":"201","author":"EL Wald","year":"2020","unstructured":"Wald EL, Sanchez-Pinto LN, Smith CM, Moran T, Badke CM, Barhight MF, et al. Hydrocortisone-ascorbic acid-thiamine use associated with lower mortality in pediatric septic shock. Am J Respir Crit Care Med. 2020;201(7):863\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"589_CR28","doi-asserted-by":"publisher","first-page":"e0129450","DOI":"10.1371\/journal.pone.0129450","volume":"10","author":"D Liu","year":"2015","unstructured":"Liu D, Su L, Han G, Yan P, Xie L. Prognostic value of procalcitonin in adult patients with sepsis: a systematic review and meta-analysis. PLoS ONE. 2015;10(6):e0129450.","journal-title":"PLoS ONE"},{"key":"589_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13054-016-1243-3","volume":"20","author":"AP Houwink","year":"2016","unstructured":"Houwink AP, Rijkenberg S, Bosman RJ, van der Voort PH. The association between lactate, mean arterial pressure, central venous oxygen saturation and peripheral temperature and mortality in severe sepsis: a retrospective cohort analysis. Crit Care. 2016;20:56.","journal-title":"Crit Care"},{"key":"589_CR30","first-page":"1","volume":"22","author":"Y Zayed","year":"2021","unstructured":"Zayed Y, Alzghoul BN, Banifadel M, Venigandla H, Hyde R, Sutchu S, et al. Vitamin C, thiamine, and hydrocortisone in the treatment of sepsis: a meta-analysis and trial sequential analysis of randomized controlled trials. J Intensive Care Med. 2021;22:1\u20137.","journal-title":"J Intensive Care Med"},{"issue":"3","key":"589_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4266\/acc.2021.00108","volume":"36","author":"MKR Somagutta","year":"2021","unstructured":"Somagutta MKR, Pormento MKL, Khan MA, Hamdan A, Hange N, Kc M, et al. The efficacy of vitamin C, thiamine, and corticosteroid therapy in adult sepsis patients: a systematic review and meta-analysis. Acute Crit Care. 2021;36(3):185\u2013200.","journal-title":"Acute Crit Care"},{"issue":"4","key":"589_CR32","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S0022-5347(17)35100-5","volume":"151","author":"TR Wandzilak","year":"1994","unstructured":"Wandzilak TR, D\u2019Andre SD, Davis PA, Williams HE. Effect of high dose vitamin C on urinary oxalate levels. J Urol. 1994;151(4):834\u20137.","journal-title":"J Urol"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-021-00589-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-021-00589-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-021-00589-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T03:30:25Z","timestamp":1674099025000},"score":1,"resource":{"primary":{"URL":"https:\/\/jintensivecare.biomedcentral.com\/articles\/10.1186\/s40560-021-00589-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s40560-021-00589-x","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}